🛡️ Public data only — no PHI permitted on this instance.

HOSP

MASSACHUSETTS EYE AND EAR INFIRMARY

CCN 220075|LOC BOSTON, MA|BEDS 41|NPR $263.9M|MARGIN -36.1%

SeekingChartis Score

INVESTMENT THESIS

Selective: MASSACHUSETTS EYE AND EAR INFIRMARY

/ 100 (C)

+$19.4M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$263.9M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

53%

CATALYSTS

▲RCM uplift of $19.4M (+736bps)

RISKS

▼Elevated distress risk (47%)

▼Small facility — limited scale economies

Hold / Selective — investigate specific opportunities but be prepared for execution risk.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$263.9M

Net Patient Revenue

-36.1%

Operating Margin

$-95.4M

Net Income

Licensed Beds

$6,436K

Revenue per Bed

$359.2M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 33%■ MEDICAID · 6%■ COMMERCIAL · 61%

Score Breakdown

SCComposite · 17/100

Component	Score	Max	%
Market Position	13	35	38%
Financial Health	0	25	0%
Operational Quality	0	20	0%
Competitive Moat	1	20	3%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
220001	HEALTHALLIANCE-CLINTON	125	$0M
220002	MOUNT AUBURN HOSPITAL	186	$0M
220008	STURDY MEMORIAL HOSPITAL	125	$0M
220010	LAWRENCE GENERAL HOSPITAL	186	$0M
220011	CAMBRIDGE HEALTH ALLIANCE	225	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN MAStart Diligence · creates a deal from HCRIS